Thermo Fisher Scientific (TMO)

Thermo Fisher's price sits roughly a fifth above where it was trading a year ago.

What is going on right now?

The stock has drifted sideways recently, sitting above its longer-term trend but without strong push in either direction. No specific news or events have been reported for the company lately.

How is the business itself doing?

Thermo Fisher makes lab equipment, chemicals, and instruments that hospitals, drug companies, and universities need every day. Revenue grew about 9% and earnings grew nearly 9%, funded by the cash the business generates itself.

What stands out?

About 94% of shares are held by large institutions, and very few people are betting against it, with only about 1.5% of shares in that camp.

What comes next?

The company's next earnings report will show whether that steady 9% growth pace is holding or shifting.